Skip to Content

FINALLY! Dabigatran reversal!

Having recognized that their "wonder drug anticoagulant" was resulting in numerous exsanguination issues in primarily elderly folks prone to fall, Boehringer found a new way to make money- drug reversal with a monoclonal. Good for them- as long as it keeps our patients alive. But remind me why we don't use the readily reversible warfarin more often...

http://www.nejm.org/doi/full/10.1056/NEJMoa1502000

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.